This product is free for DNS members.
This webinar was presented live on June 9, 2020.
This is part three of a multi-part series that provides critical information related to updates in IV lipid emulsions. This component, provided by practicing RDNs, will focus on the role of various IV lipid emulsions in the inflammatory process.
Financial support for this webinar series is provided by Baxter.
CPE Level: 2
Learning Need Codes: 5440, 5220, 3070
Performance Indicators: 10.4.3, 4.1.4, 8.1.5
- Understand the history of lipid injectable emulsions (ILEs) and the composition of commercially available ILEs in the United States.
- Learn about various mechanisms in which fatty acids may inhibit or heighten the inflammatory response and subsequent development of infections in hospitalized patients.
- Evaluate the literature in terms of the relationship between the use of olive oil-based or supplemental fish oil ILE and incidence of infection and duration of hospital length of stay in hospitalized, non-critically ill patients receiving commercially available ILEs.
Andrew Evans, MBA, RD, LD
Heather Stanner MS, RD, LDN